Spinal Cord Stimulation — CPB 0194 | AETNA Coverage Update

Aetna modified CPB 0194 for spinal cord stimulation, effective February 25, 2026. Here's what billing teams need to know.

Aetna, a CVS Health company, updated its spinal cord stimulation coverage policy under CPB 0194 in the Aetna CPB 0194 system, with changes that tighten the criteria your team must document before billing CPT 63650, 63655, or related implantation codes. The update adds a formal Oswestry Disability Index (ODI) threshold, specifies that physical therapy must be in-person (not virtual), and draws a hard line around 3D neural targeting and other SCS modalities — designating them not covered when billed under the core implantation codes. If your practice handles spinal cord stimulation billing for FBSS, CRPS, or neuropathic pain patients, audit your documentation workflows before submitting claims against this revised policy.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Spinal Cord Stimulation
Policy Code	CPB 0194
Change Type	Modified
Effective Date	February 25, 2026
Impact Level	High
Specialties Affected	Pain Management, Neurosurgery, Neurology, Interventional Spine, Cardiology (intractable angina subset)
Key Action	Verify ODI score ≥ 21% and in-person PT documentation are in the chart before submitting implantation claims

---

Aetna Spinal Cord Stimulation Coverage Criteria and Medical Necessity Requirements 2026

Aetna's spinal cord stimulation coverage policy under CPB 0194 covers a trial of percutaneous dorsal column stimulation for four clinical indications. Medical necessity approval requires meeting the indication AND all six cross-cutting criteria simultaneously. There is no flexibility here — it's a conjunctive list.

The four covered indications:

All six cross-cutting criteria must be met:

The ODI ≥ 21% threshold is an explicit documented requirement under the current policy. Verify your documentation workflow includes it. Your team needs the ODI score in the chart — if the clinician hasn't administered it, the claim is at risk.

Once the trial clears these hurdles, implantation of the dorsal column stimulator (billed under CPT 63650 for percutaneous electrode array or CPT 63655 for paddle via laminectomy) requires 50% or more pain reduction during a 3- to 7-day percutaneous trial. Document that threshold explicitly in the trial summary note — not just a statement that the trial "was successful."

Reimbursement for the device components flows through HCPCS codes. Rechargeable generators bill under C1820 (non-high-frequency) or C1822 (high-frequency). Non-rechargeable generators use C1767 or L8686. Lead implants use C1778 or L8679 for the pulse generator. Make sure device billing matches what was actually implanted — payers cross-reference implant logs against billed HCPCS codes.

This policy does not explicitly address prior authorization requirements. Confirm PA requirements through Aetna's standard pre-authorization process or provider portal before submitting claims.

---

Aetna Spinal Cord Stimulation Exclusions and Non-Covered Indications

This is where the February 25, 2026 update gets specific and where your team will see the most claim denial risk.

3D neural targeting SCS — not covered. Aetna explicitly does not cover 3D neural targeting spinal cord stimulation when billed under the core implantation codes CPT 63650, 63655, 63661, 63662, 63663, 63664, 63685, or 63688. The intraoperative neurophysiology monitoring codes (CPT 95925–95929, 95938, 95939, +95940, +95941, and G0453) are listed in the context of 3D neural targeting with no specific coverage determination — meaning they're not explicitly approved for this indication.

The real issue here is that 3D neural targeting is becoming more common in implant suites, and some teams may be bundling the neurophysiology monitoring codes as standard components of an SCS implant. Aetna is drawing a clear line: the technique is not covered, and neither is the monitoring infrastructure supporting it.

Other non-covered categories based on the policy structure:

If you're billing for any SCS-adjacent neurophysiology monitoring, loop in your compliance officer before the effective date. The grouping of CPT 95925–95939, +95940, and +95941 under "3D neural targeting — no specific coverage" creates real ambiguity for cases where these codes are used for standard intraoperative monitoring rather than 3D targeting.

---

Coverage Indications at a Glance

---

Aetna Spinal Cord Stimulation Billing Guidelines and Action Items 2026

These are the changes that require workflow updates before February 25, 2026 or for any claims submitted under the revised policy.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Spinal Cord Stimulation Under CPB 0194

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Not Covered / Experimental Codes — 3D Neural Targeting Context

HCPCS Device and Equipment Codes

Key ICD-10-CM Diagnosis Codes

This policy covers 536 ICD-10-CM codes. The table below shows representative covered diagnoses. Your billing team should cross-reference the full code list in CPB 0194 at the Aetna source.

The full 536-code ICD-10 list covers diabetic neuropathy across multiple diabetes subtypes (E08–E13 series), herpes zoster neuralgia, malignant and benign neoplasms, and a wide range of neuropathic and spinal pain diagnoses. Confirm that your primary diagnosis code maps to the covered list before submitting — a valid indication with an unmapped ICD-10 code is still a claim denial waiting to happen.

---